Omega‐3 vs placeboQoL · Apathy in people with mild‐to‐moderate Alzheimer's disease2 findings from 1 reviewOmega‐3 fatty acids for the treatment of dementia 2016 · Cochrane Headline outcomes onlyno estimate extracted1 study · 269 participantsModerateOmega‐3 fatty acids for the treatment of dementia 2016 · Cochrane Headline outcomes onlyno estimate extracted1 study · 332 participantsHigh